History [edit] Descriptions of deficiency effects [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy
VKTX patents expire in 2037
Figure 2 illustrates that CVOTs consistently demonstrate a reduction in major adverse cardiovascular events (MACE) with either GLP-1RA or SGLT2i monotherapy, whereas combination therapy shows a uniform but non-statistically significant reduction
In cases where the source of the bleed is unclear, but melena is present, an upper endoscopy is recommended, to try to ascertain the source of the bleed
Robert Kushner: GLP-1 appears to be a strong enough regulator, dealing with the appetite dysregulation, to really harmonize my understanding harmonize all these other factors you're talking about
